Association of generalized anxiety disorder with autonomic hypersensitivity and blunted ventromedial prefrontal cortex activity during peripheral adrenergic stimulation: A randomized clinical trial
JAMA Feb 05, 2022
Researchers examined if there are abnormal physiological, perceptual, or neural responses among individuals with generalized anxiety disorder (GAD) during peripheral β-adrenergic stimulation that may indicate interoceptive dysfunction.
In his crossover randomized clinical trial, researchers included 58 women with artifact-free data [29 with GAD (mean [SD] age, 26.9 [6.8] years) and 29 matched healthy comparators (mean [SD] age, 24.4 [5.0] years)].
Neural responses were assessed using functional magnetic resonance imaging during randomized intravenous bolus infusions of isoproterenol (0.5 and 2.0 μg) and saline, each administered twice in a double-blind fashion.
Relative to healthy participants, female patients with GAD showed hypersensitivity to adrenergic stimulation as well as greater interoceptive sensation and reduced ventromedial prefrontal cortex activity.
Findings overall support contribution of dysfunctional autonomic and central nervous system to the pathophysiology of GAD and suggest the possibility of the ventromedial prefrontal cortex to be a treatment target.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries